Bildkälla: Stockfoto

Xbrane Biopharma: Initial Take on Encouraging Results - Redeye

Redeye gives its initial impressions regarding the release of Xbrane’s positive interim data from its phase III study Xplore. Following the scheduled webcast, we will return with a more detailed note.

Redeye gives its initial impressions regarding the release of Xbrane’s positive interim data from its phase III study Xplore. Following the scheduled webcast, we will return with a more detailed note.
Börsvärldens nyhetsbrev
ANNONSER